Benzylamine

Benzylamine Market Intelligence Report (June 2026)

I. Price Dynamics
1. Mainstream Quotations
– Domestic benzylamine (purity ≥99%) remains stable at RMB 25,000 per metric ton. Quotations from Shandong Aite Chemical Co., Ltd., Changzhou Aozun Composite New Materials Co., Ltd., and Wuhan Baiyite Chemical Co., Ltd. have held steady for multiple consecutive days.
– High-purity specialty products—e.g., R(+)-α-methylbenzylamine (purity 99%)—command significant premiums: Shandong Yuxuan Chemical’s February quotation reached RMB 80,000 per metric ton, reflecting pronounced market segmentation driven by demand for customized, high-value-added derivatives.
– In the small-batch spot market, aggressive price competition exists: Wuhan Xinxin Jiali Biotechnology Co., Ltd. quoted as low as RMB 1,000 per metric ton (minimum order quantity: 1 ton); however, specifications and intended applications remain unspecified—these offerings likely represent low-purity material or process by-products.

2. Historical Price Trends
– Prices in 2025 followed a “decline-then-recovery” pattern: beginning the year at ~RMB 38,500/ton, declining to RMB 34,200/ton mid-year due to intensified competition amid capacity expansion, and rebounding to RMB 41,800/ton by year-end, fueled by rising demand for high-purity grades and constraints on imported raw materials.
– In early 2026, price volatility narrowed; quotations stabilized between RMB 40,000–42,000/ton in February, and prices have since remained at relatively low levels since April, reflecting balanced supply-demand conditions.

II. Supply-Demand Analysis
1. Supply Side
– Capacity Distribution: China’s benzylamine production capacity is highly concentrated in the East China region (Jiangsu and Zhejiang provinces), accounting for over 70% of national capacity. A core industrial cluster has formed around Yangtze River Pharmaceutical Group, Zhejiang Yongtai Technology Co., Ltd., and Jiangsu Zhongdan Group. As of end-2025, China’s effective annual capacity reached 12,500 metric tons—a 52.4% increase versus 2021.
– Technological Upgrades: Catalytic hydrogenation has largely replaced the traditional aluminum-amalgam reduction method; clean production processes accounted for over 75% of total output in 2025. Adoption of continuous-flow microreactor synthesis technology rose to 65%, reducing unit production costs by 28%.
– Environmental Compliance Pressure: The newly revised “Emission Standards for Pollutants from the Chemical Raw Materials Industry” tightened COD limits for benzylamine production wastewater to 80 mg/L, doubling average environmental operating costs per ton to over RMB 2,600—accelerating the exit of outdated, non-compliant capacity.
– Regional Competition: The Yangtze River Delta hosts a mature cluster led by Shanghai Hile BioTech (WuXi AppTec) and Zhejiang Xinhua Chemical, collectively accounting for 58% of national capacity. A new 200,000-ton/year benzylamine production base in Lianyungang is currently undergoing equipment commissioning, potentially intensifying regional competition.

2. Demand Side
– Agrochemicals: Accounts for ~40% of total demand; used primarily in synthesizing efficient, low-toxicity pesticides such as benzylamine benzoate. Global agrochemical demand is projected to reach 500,000 metric tons in 2025.
– Pharmaceuticals: Represents ~32% of demand; serves as a key intermediate in synthesizing antibiotics (e.g., cefixime) and antitumor agents. Its share is expected to rise to 40% by 2030, with pricing benchmarks for pharmaceutical-grade products anticipated to increase by 8–10%.
– Fragrances & Flavors: Used in producing benzyl benzoate, benzyl alcohol, etc. The global flavor & fragrance market is projected to grow from USD 18 billion in 2018 to USD 30 billion in 2025.
– Demand Elasticity: Premiums for high-purity grades (≥99.5%) range between 12–15%, underscoring industry-wide transition toward quality-driven growth—and custom synthesis services are increasingly enabling differentiated pricing strategies.

III. Competitive Landscape
1. High-End Segment: Enterprises such as Zhejiang Yongtai and Jiangsu Zhongdan dominate this tier, leveraging electronic-grade mass-production capabilities, vertically integrated raw material sourcing, and internationally recognized certifications—achieving gross margins exceeding 43%.
2. Mid-Low Tier: Low-value, high-barrier firms rely on localized environmental infrastructure to sustain operations but face progressive marginalization; low-value, low-barrier small-scale producers are exiting rapidly.
3. Substitution Threats: Novel fluorinated building blocks are increasingly displacing conventional benzylamine routes—particularly in pharmaceutical intermediates.
4. Trade Barriers: Tightening EU REACH regulations, U.S. EPA oversight, and the potential implementation of the EU Carbon Border Adjustment Mechanism (CBAM) are compelling enterprises to accelerate green process upgrades.

IV. Policy & Cost Factors
1. Policy Support: National strategic emerging industry development policies provide financial support for technological upgrading and encourage vertical integration into high-value-added segments.
2. Cost Pressures: Wastewater pretreatment and hazardous waste disposal costs now account for 5–7% of total production expenses, with labor and environmental compliance costs projected to rise at an annualized rate of 5–7% over the next five years.
3. Industry Concentration: Rising environmental compliance costs are driving consolidation: the CR5 (combined market share of the top five enterprises) is expected to climb from the current 45% to over 65% by 2027–2030.

V. Future Outlook (2026–2030)
1. Price Trend
– Short Term (2026): Prices are expected to remain subdued under balanced supply-demand conditions, with mainstream quotations stabilizing at RMB 25,000–26,000 per metric ton.
– Medium-to-Long Term (2027–2030): Gradual upward pressure on pricing benchmarks is anticipated, driven by growing demand for high-purity grades and escalating environmental compliance costs—especially for pharmaceutical-grade products, whose premium rates will likely widen.

2. Supply-Side Evolution
– Further geographic concentration in East China; commissioning of the Lianyungang mega-base may intensify regional rivalry; environmental regulation continues to accelerate the retirement of obsolete capacity, further elevating industry concentration.

3. Demand-Side Evolution
– Sustained growth in agrochemical and pharmaceutical applications; expanding fragrance markets generate incremental demand; increasing share of high-purity grades and rising importance of custom synthesis services as key competitive differentiators.

4. Technological Trajectory
– Wider adoption of green synthesis technologies—including catalytic hydrogenation and continuous-flow microreactors—will drive down unit costs; accelerated R&D into biocatalytic (enzyme-based) synthesis methods supports broader decarbonization goals.

5. Key Risk Factors
– Volatility in import dependency for critical feedstocks (e.g., benzyl chloride);
– Disruptive breakthroughs in alternative synthetic platforms threatening existing market share.